2020-10-21 07:56
(180 d 09:46 ago)

Posting: # 22041
Views: 547

 Data manipulation / fraud in BE [Study As­sess­ment]

Hi all,

a new paper was published dealing with detection of data integrity issues in BE, in particular a type of fraud that is prevalent according to regulators. The manipulation does not leave a paper trail or audit trail, and is not necessarily visible by onsite inspection. But it can be visualised or detected by certain analyses.

Regulators have been making extensive use of analyses produced through the software software described in the paper ("Buster" and "SaToWIB" routines) and it has been used to raise potential serious risks to public health and thus for referral triggering.

You can find the paper here.

Pass or fail!
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 6 (0 registered, 6 guests [including 1 identified bots]).
Forum time: Monday 17:42 UTC (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz